CME Grant Disclosure 2011 and 1st ½ of 2102

0 1,297

We have compiled a chart of companies that disclose their educational grant payments for  2011 and 2012.  Once the final Physician Payment Sunshine Act regulations are, it is likely that more companies will begin to post such payments to teaching hospitals in anticipation of the rules to assist with implementation and compliance. It should be noted that many companies
are posting rolling grants payments rather than cumulative grants
payments. This means that current postings may not reflect historical
transparency posting, but instead current year or last 4 quarters (2
common methods used).  So, for example, Janssen Pharmaceuticals has
posted grants payments since 2010 but only current year Q1-Q2 (the most
recent report) is available on our site.

Company 2012 2011 2010 2009 2008
Abbott   Q1 Q1 Q1  
    Q2 Q2 Q2  
    Q3 Q3 Q3 Q3
    Q4 Q4 Q4 Q4
           
Allergan Q1 & Q2 Q1 & Q2      
    Q3 & Q4 Q3    
           
Amgen Q1 Q1 Q1 Q1 Q1
  Q2 Q2 Q2 Q2 Q2
    Q3 Q3 Q3 Q3
    Q4 Q4 Q4 Q4
           
Amilyn Q1 & Q2  2011 Q1 Q1  
      Q2 Q2  
      Q3 Q3  
        Q4  
           
Amilyn Lilly Grant Office     Q1 Q1  
      Q2 Q2  
      Q3 Q3  
        Q4  
Astellas Pharma US, Inc. Q1 Q1 Q1 Q4  
  Q2 Q2 Q2    
    Q3 Q3    
    Q4 Q4    
           
Astra Zeneca Q1& Q2 2012 Q1 & Q2 2011 Q1 & Q2 2010 Q1 & Q2 2009 Q1 & Q2 2008
    Q3 &Q4 2011  Q3 &Q4 2010  Q3 &Q4 2009  Q3 &Q4 2008
           
Bristol-Myers Squibb Q1 Q1 Q1    
  Q2 Q2 Q2    
    Q3 Q3    
    Q4 Q4    
           
GlaxoSmithKline Q1 & Q2 2012 Full Year Full Year Full Year Full Year 2008
           
Genentech   Q1 Q1    
    Q2 Q2    
      Q3    
      Q4    
           
Forest Labs Q1 Full Year Full Year    
Johnson and Johnson Companies          
           
Biosense Webster Q1 2012; Q2-Q4 2011        
Janssen Biotech Q1 & Q2 Q1 & Q2 2011      
Cordis Q1 2012; Q2-Q4 2011        
Depuy Mitek, Inc. Q1 2012; Q2-Q4 2011        
Depuy Orthopaedics, Inc. Q1 2012; Q2-Q4 2011 Q1 2011 – Q1 2010      
Depuy Spine, Inc. Q1 2012; Q2-Q4 2011 Q1 2011 – Q2 2010      
Codman and Shurtleff, Inc. Q1 2012; Q2-Q4 2011 Q1 2011 – Q2 2010      
Ethicon Q1 2012; Q2-Q4 2011 Q1 2011 – Q2 2010      
Ethicon Endo Surgery, Inc.          
Janssen Pharmaceuticals, Inc. Q2        
Janessen Biotech, Inc.   Q1 2011      
Janssen Therapeutics Q2        
Therakos Q1 2012; Q2-Q4 2011        
Eli Lilly   Full Year Full Year Full Year  
           
Merck Q1 Q1 Q1 Q1 Q3
  Q2 Q2 Q2 Q2 Q4
    Q3 Q3 Q3  
    Q4 Q4 Q4  
           
Pfizer Q1 &Q2 2011 2010 2009 2008
           
Sanofi Aventis Q1 Q1 Q1 Q1  
    Q2 Q2 Q2  
    Q3 Q3 Q3  
    Q4 Q4 Q4  
           
Shire Q1 Q1 Q1 Q1  
  Q2 Q2 Q2 Q2  
    Q3 Q3 Q3  
    Q4 Q4 Q4  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Leave A Reply

Your email address will not be published.